© BusinessWire
07.01.2026
PBYI
LISTED
NASDAQ
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on January 6, 2026, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 10,500 shares of Puma common stock to three new non-executive employees.
The awards were granted under Puma’s 2017...
Themefolio
Profiler
Peergroup
© Newsfile
07.01.2026
EPIC
LISTED
CSE
SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan
News Preview
Edmonton, Alberta and Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") are pleased to announce that SNDL has completed the acquisition of 5 cannabis retail stores located in Alberta and Saskatchewan from 1CM. The transaction represents th...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
SRTS
LISTED
NASDAQ
Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco
News Preview
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced that management will be meeting with members of the healthcare investment community January 12–14, 2026, in San Franci...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
07.01.2026
TBRG
LISTED
NASDAQ
TruBridge Announces Extension of Cooperation Agreement with Pinetree Capital
News Preview
TruBridge, Inc. (“TruBridge” or the “Company”) (NASDAQ: TBRG), a healthcare solutions company, today announced that it has agreed to extend its cooperation agreement with Pinetree Capital Ltd. and L6 Holdings Inc. (together, “Pinetree”). Pinetree is the Company’s largest shareholder. Pursuant to the cooperation agreement, TruBridge will appoint Da...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
07.01.2026
VTYX
LISTED
NASDAQ
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
News Preview
Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation Acquisition builds on Lilly's established capabilities in inflammatory-mediated diseasesINDIANAPOLIS, Jan. 7, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Ventyx Biosciences, Inc. (Nasdaq: VTYX), a San Diego-...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
NVST
LISTED
NYSE
Envista to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
BREA, Calif., Jan. 7, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 12, 2026, from 3:45 – 4:25 pm PST. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
LENZ
LISTED
NASDAQ
LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates
News Preview
Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
RCUS
LISTED
NYSE
Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs
News Preview
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases, today outlined its 2026 priorities for casdatifan and its emerging inflammation and immunology (I&I) programs.
“As we enter 2026, the highest...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
AMGN
LISTED
NASDAQ
AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
News Preview
THOUSAND OAKS, Calif., Jan. 7, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2026 J.P. Morgan Healthcare Conference at 3:45 p.m. PT on Monday, January 12, 2026. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
BRKR
LISTED
NASDAQ
Bruker Corporation to Present at the J.P. Morgan Healthcare Conference
News Preview
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 45th annual J.P. Morgan Healthcare Conference in San Francisco. Senior leadership will present on behalf of the Company on Monday, January 12th, 2026 at 9:00 AM Pacific Standard Time.
A live audio webcast of the presentation will be available on the Investor Relations s...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
TKOMF
LISTED
OTC
Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 14, 2026 at 11:15 a.m. PT.
The presentation and question and answer session will be webcast live and can be accessed by visiting the Inves...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
MLAB
LISTED
NASDAQ
MESA LABS DECLARES QUARTERLY DIVIDEND
News Preview
LAKEWOOD, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 16, 2026, to shareholders of record at the close of business...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
07.01.2026
ALVO
LISTED
ICE
Correction: Transactions of Managers and Closely Associated Persons
News Preview
Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons. ATP Holdings ehf. announced two transactions, an acquisition of 4,812,257 shares in Alvotech on December 17, 2025, and a sale of 2,110,640 shares in Alvotech on December 19,...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
SNDL
LISTED
NASDAQ
SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan
News Preview
EDMONTON, Alberta and TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (Nasdaq: SNDL, CSE: SNDL) (“SNDL”) and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) (“1CM”) are pleased to announce that SNDL has completed the acquisition of 5 cannabis retail stores located in Alberta and Saskatchewan from 1CM....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
JSPR
LISTED
NASDAQ
Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth
News Preview
Thomas Wiggans appointed Executive Chairperson ...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
GMED
LISTED
NYSE
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
News Preview
AUDUBON, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ended December 31, 2025. The company anticipates fourth quarter 2025 sales of approximately $823.2 million, an increase of 25.2 per...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
SANA
LISTED
NASDAQ
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. PT on Wednesday, January 14, 2026. The presentation will featu...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
RAPT
LISTED
NASDAQ
RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that Brian Wong, M.D., Ph.D., Pr...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
RARE
LISTED
NASDAQ
Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
NOVATO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's chief executive officer and president, wi...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
STRO
LISTED
NASDAQ
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Jane Chung, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Co...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
DH
LISTED
NASDAQ
Definitive Healthcare to Present at the 28th Annual Needham Growth Conference
News Preview
FRAMINGHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Chief Financial Officer, Casey Heller, will present at the 28th Annual Needham Growth Conference....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
KRYS
LISTED
NASDAQ
Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis
News Preview
Investor call to be held January 8 at 4:30 pm ET to discuss data update and next steps Investor call to be held January 8 at 4:30 pm ET to discuss data update and next steps...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
ANNX
LISTED
NASDAQ
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, president and chief executive officer, will present...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
PHAT
LISTED
NASDAQ
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
News Preview
FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock or, in...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
TTRX
LISTED
NASDAQ
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
News Preview
Mr. Dewhurst Brings Over 30 Years of Life Sciences and M&A Experience to the Board, Aligning with the Company’s Strategic Long-Term Goals for Growth and Expansion Mr. Dewhurst Brings Over 30 Years of Life Sciences and M&A Experience to the Board, Aligning with the Company’s Strategic Long-Term Goals for Growth and Expansion...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
VEEV
LISTED
NYSE
Internationale Geschäftsabteilung von Novo Nordisk entscheidet sich für Veeva Vault CRM
News Preview
Entscheidung für das branchenführende Vault CRM, um Vertriebsteams mit CRM-Funktionen der nächsten Generation und agentenbasierter KI zu unterstützenPLEASANTON, Kalifornien, 7. Januar 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) gab heute bekannt, dass sich die internationale Geschäftsabteilung von Novo Nordisk für die Nutzung von Veeva Vault C...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
PFE
LISTED
NYSE
Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio
News Preview
At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, as more than 2,100 women pursue litigation alleging Pfizer failed to adequately warn patients despite long-standing knowledge of the risk.
The hear...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
SOBI
LISTED
STO
Sobi to advance Gamifant® (emapalumab) in interferon-gamma-driven sepsis (IDS) based on EMBRACE topline data
News Preview
STOCKHOLM, Jan. 7, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for interferon-gamma (IFNγ)-driven sepsis (IDS), showed proof-of-concept with observed improvement in organ dysfunction and survival.
Based on the observed data from this research collabor...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
SOBI
LISTED
STO
Sobi to advance Gamifant® (emapalumab) in interferon-gamma-driven sepsis (IDS) based on EMBRACE topline data
News Preview
STOCKHOLM, Jan. 7, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for interferon-gamma (IFNγ)-driven sepsis (IDS), showed proof-of-concept with observed improvement in organ dysfunction and survival.
Based on the observed data from this research collabor...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Transaction in Own Shares
News Preview
For immediate release
7 January 2026
WORLDWIDE HEALTHCARE TRUST PLC
(the "Company")
MARKET PURCHASE...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
EQS
LISTED
EURONEXT
BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT
News Preview
BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT ...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
HRTIS
LISTED
HEL
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease
News Preview
Herantis Pharma Plc – Company release...
Themefolio
Profiler
Peergroup
© ActuNews
07.01.2026
BLC
LISTED
EURONEXT
BASTIDE : 2026.01.07 - BCM - bilan S2 contrat liquidité 2025
News Preview
BASTIDE LE CONFORT MEDICAL
Société anonyme au capital de 3.360.847,05 €
Siège social : 12 Avenue de la Dame - 30132 CAISSARGUES
305 635 039 RCS NIMES
Bilan du second semestre civil du contrat de liquidité
contracté avec la Société de Bourse Gilbert Dupont
Titre concerné...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
IPN
LISTED
EURONEXT
Ipsen - December 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
News Preview
Monthly information relative to the total number of voting rights and shares composing the share capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
AB
LISTED
EURONEXT
AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
News Preview
PRESS RELEASE...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
GNFT
LISTED
EURONEXT
GENFIT Announces 2026 Financial Calendar
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 7, 2026 - GENFIT (Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its provisional financial calendar for 2026....
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
BCTX
LISTED
NASDAQ
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
News Preview
Issued on behalf of Oncolytics Biotech Inc. USANewsGroup.com News CommentaryVANCOUVER, BC, Jan. 7, 2026 /CNW/ -- The global cancer drugs market is surging toward $594.3 billion by 2035 as high-tech immunotherapies begin to replace traditional chemotherapy[1]. With response rates now exceeding 90% in some previously untreatable blood cancers, these...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
BCTX
LISTED
NASDAQ
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
News Preview
Issued on behalf of Oncolytics Biotech Inc. USANewsGroup.com News CommentaryVANCOUVER, BC, Jan. 7, 2026 /PRNewswire/ -- The global cancer drugs market is surging toward $594.3 billion by 2035 as high-tech immunotherapies begin to replace traditional chemotherapy[1]. With response rates now exceeding 90% in some previously untreatable blood cancers...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
CI
LISTED
NYSE
Hankook Tire Opens New Onsite Health Clinic for Employees and Their Families at Tennessee Plant
News Preview
New Hankook Tire Clinic Powered by Evernorth offers convenient primary and preventive care at the Clarksville, Tenn. manufacturing plantOnsite clinic provides low- or no-cost access for eligible employees, spouses and dependents, including in-person and virtual visitsInvestment reinforces Hankook Tire's commitment to the health and well-being of i...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
MDT
LISTED
NYSE
Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus
News Preview
GALWAY, Ireland, Jan. 7, 2026 /PRNewswire/ -- A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMed™ 780G system achieved American Diabetes Association (ADA) recommended goals for time-in-range (TIR)— even on days when mealtime boluses were missed. CareLink™ data showed that the studied user population...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
ABT
LISTED
NYSE
Abbott's FreeStyle Libre 3 Plus Now Covered Across Canada
News Preview
Coverage means more Canadians with diabetes can access Abbott's sensor-based glucose technology, giving them actionable insights to manage their condition confidently,iAbbott's latest innovation, the FreeStyle Libre 3 Plus* sensor, is easy to apply, ii easy to useiii and features the world's smallest glucose sensor, iv,v providing users with accur...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
CDXS
LISTED
NASDAQ
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics
News Preview
REDWOOD CITY, Calif., Jan. 7, 2026 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of LGC Group, an oligonucleotide Contract Research Development and Manufacturing organization (CRDMO), today announced that they have entered into an agre...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
ELVN
LISTED
NASDAQ
Enliven Therapeutics Bolsters Board to Prepare for Next Phase of Development
News Preview
Scott Garland, a seasoned biopharma executive with a strong track record of leading successful companies and drug launches, joins Enliven's Board of DirectorsBuilding on positive data reported in 2025, Enliven continues to prepare for Phase 3 trial initiation in 2026 and the commercialization of ELVN-001BOULDER, Colo., Jan. 7, 2026 /PRNewswire/ --...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
CDXS
LISTED
NASDAQ
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics
News Preview
REDWOOD CITY, Calif., Jan. 7, 2026 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of LGC Group, an oligonucleotide Contract Research Development and Manufacturing organization (CRDMO), today announced that they have entered into an agre...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
DXCM
LISTED
NASDAQ
Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer
News Preview
DexCom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, is ushering in the next era of transformative, customer-driven innovation under the leadership of President and CEO Jake Leach, who assumed his expanded responsibilities on Jan. 1.
This press release features multimedia. View the full release here: https://www.businesswire.com/n...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
GMAB
LISTED
NASDAQ
Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence
News Preview
Genmab A/S (Nasdaq: GMAB) announced today a partnership with Anthropic to advance and enhance the company’s research and development (R&D) processes through the adoption of cutting-edge artificial intelligence (AI) capabilities.
Under the agreement, Genmab and Anthropic will design and deploy custom, Claude-powered agentic AI solutions to su...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
THC
LISTED
NYSE
Tenet to Report its Fourth Quarter 2025 Results on February 11th
News Preview
Tenet Healthcare Corporation (NYSE: THC) will release its fourth quarter 2025 results before the market opens on Wednesday, February 11, 2026, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time).
A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
MASI
LISTED
NASDAQ
Masimo to Present in the J.P. Morgan 2026 Healthcare Conference
News Preview
Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation....
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
ORMP
LISTED
TLV
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
News Preview
Payment Closes Out Option Agreement Obligations; Oramed Retains $39 Million Outstanding debt, Convertible Debt, Warrants, and an Ongoing Royalty InterestNEW YORK, Jan. 7, 2026 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) today announced it has received an $18 million payment from Scilex Holdings Inc., representing full s...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
SERA
LISTED
NASDAQ
Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications
News Preview
Published in the journal PREGNANCY, the PRIME Study demonstrates significant improvements in neonatal outcomes with early risk screening and targeted interventions.SALT LAKE CITY, Jan. 7, 2026 /PRNewswire/ -- A randomized controlled trial of 5,018 women has found that a simple blood test, when paired with targeted interventions, can significantly...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS7 JANUARY 2026 at 16:30 EET ...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
WGS
LISTED
NASDAQ
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced GenomeDx Prenatal™, whole genome sequencing (WGS) designed to deliver clear, reliable answers during one of the most critical moments in pregnancy care. The phenotype-informed, trio-based test is intended for pregnancies with fetal anoma...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
SRTS
LISTED
NASDAQ
Sensus Healthcare Appoints Larry Biscotti to its Board of Directors
News Preview
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the appointment of Larry Biscotti to its Board of Directors, effective immediately. With this appointment the Sensus H...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
SRPT
LISTED
NASDAQ
Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease
News Preview
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the submission of its clinical trial application (CTA) for Study SRP-1005-101, also known as INSIGHTT, to Medsafe, the New Zealand Medicines and Medical Devices Safety Authority. Pending approval, Sarepta expects to initiate this f...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
INGN
LISTED
NASDAQ
Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States
News Preview
Inogen, Inc. (Nasdaq: INGN), a leading medical technology company specializing in innovative respiratory products for homecare use, today announced the launch of Aurora CPAP masks, a new product within the expanding Inogen portfolio. Aurora’s introduction marks a significant milestone in Inogen’s strategy to expand its respiratory care portfolio a...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
NGHI
LISTED
OTC
New Green Hemp, Inc. Appoints Attorney Michael Minardi to Board of Directors to Strengthen Governance and Regulatory Strategy
News Preview
New Green Hemp, Inc. Appoints Attorney Michael Minardi to Board of Directors to Strengthen Governance and Regulatory Strategy...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
CERO
LISTED
NASDAQ
CERo Therapeutics Provides Clinical Update on Phase 1 Trial of CER-1236 in AML (CertainT-1) Highlighting Key Safety Data and Platelet Transfusion–Free Interval Observed in a Patient with Myelodysplastic Syndrome/AML
News Preview
Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
RIGL
LISTED
NASDAQ
Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SOUTH SAN FRANCISCO, Calif., Jan. 7, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference in San...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
HRMY
LISTED
NASDAQ
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced its participation in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Jeffrey M. Dayno, M.D., President and Chief Executive Officer, is scheduled to present at the conference on Tuesday, January 13, 2026, at 4:30 p.m. PT / 7:30 p.m. ET.
A webcast of the presenta...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
